Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality

BACKGROUND AND AIMS: Patients with severe coronavirus disease 2019 (COVID‐19) are at significant risk of thrombotic complications. However, their prothrombotic state is incompletely understood. Therefore, we measured in vivo activation markers of hemostasis, plasma levels of hemostatic proteins, and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Res Pract Thromb Haemost
Päätekijät: von Meijenfeldt, Fien A., Havervall, Sebastian, Adelmeijer, Jelle, Lundström, Annika, Rudberg, Ann‐Sofie, Magnusson, Maria, Mackman, Nigel, Thalin, Charlotte, Lisman, Ton
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles ‐ Thrombosis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7845083/
https://ncbi.nlm.nih.gov/pubmed/33537537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12462
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia